Kamada (KMDA) Depreciation and Depletion (2017 - 2025)
Kamada (KMDA) posted quarterly Depreciation and Depletion of $3.8 million for Q3 2025, up 15.98% year-on-year from $3.2 million in Q3 2024, and little changed on a QoQ basis from $3.7 million in Q2 2025.
Kamada (KMDA) Depreciation and Depletion (2017 - 2025) Analysis & Trends
Kamada (KMDA) has reported Depreciation and Depletion for 9 consecutive years, with $3.8 million the latest figure, recorded in Q3 2025.
- Quarterly Depreciation and Depletion rose 15.98% year-over-year to $3.8 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $14.8 million (up 53.81% YoY) and the FY2024 annual result came in at $13.8 million, up 8.6% from the prior year.
- Depreciation and Depletion steadied at $3.8 million in Q3 2025 per KMDA's latest filing, from $3.7 million in the prior quarter.
- Over the last five years, Depreciation and Depletion for KMDA reached as high as $4.1 million in Q4 2024 and fell as low as $1997.0 in Q4 2021.
- A 5-year average of $2.2 million and a median of $3.1 million in 2022 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2021 — Depreciation and Depletion slumped 99.84% — and 2024, when it jumped 127705.49%.
- Year by year, Depreciation and Depletion stood at $1997.0 in 2021, then surged by 50.83% to $3012.0 in 2022, then climbed by 6.51% to $3208.0 in 2023, then soared by 127705.49% to $4.1 million in 2024, then declined by 8.29% to $3.8 million in 2025.
- According to Business Quant data, Depreciation and Depletion over the past three periods registered $3.8 million, $3.7 million, and $4.1 million for Q3 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 36.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 28.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3.76 Mn |
| Sep 30, 2025 | 3.76 Mn |
| Jun 30, 2025 | 3.75 Mn |
| Jun 30, 2025 | 3.75 Mn |
| Dec 31, 2024 | 4.10 Mn |
| Dec 31, 2024 | 4.10 Mn |
| Sep 30, 2024 | 3.24 Mn |
| Sep 30, 2024 | 3.24 Mn |
| Jun 30, 2024 | 3.23 Mn |
| Jun 30, 2024 | 3.23 Mn |
| Dec 31, 2023 | 3,208.00 |
| Dec 31, 2023 | 3,208.00 |
| Sep 30, 2023 | 3.18 Mn |
| Sep 30, 2023 | 3.18 Mn |
| Jun 30, 2023 | 3.20 Mn |
| Jun 30, 2023 | 3.20 Mn |
| Mar 31, 2023 | 3.12 Mn |
| Mar 31, 2023 | 3.12 Mn |
| Dec 31, 2022 | 3,012.00 |
| Dec 31, 2022 | 3,012.00 |